Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents

详细信息    查看全文

• 作者：Mathew P. Leese ; Fabrice L. Jourdan ; Keira Gaukroger ; Mary F. Mahon ; Simon P. Newman ; Paul A. Foster ; Chloe Stengel ; Sandra Regis-Lydi ; Eric Ferrandis ; Anna Di Fiore ; Giuseppina De Simone ; Claudiu T.
• 刊名：Journal of Medicinal Chemistry
• 出版年：2008
• 出版时间：March 13, 2008
• 年：2008
• 卷：51
• 期：5
• 页码：1295 - 1308
• 全文大小：1190K
• 年卷期：v.51,no.5(March 13, 2008)
• ISSN：1520-4804

文摘

The synthesis, SAR, and preclinical evaluation of 17-cyanated 2-substituted estra-1,3,5(10)-trienes as anticancer agents are discussed. 2-Methoxy-17β-cyanomethylestra-1,3,5(10)-trien-3-ol (14), but not the related 2-ethyl derivative 7, and the related 3-O-sulfamates 8 and 15 display potent antiproliferative effects (MCF-7 GI₅₀ 300, 60 and 70 nM, respectively) against human cancer cells in vitro. Investigation of the SAR reveals that a sterically unhindered hydrogen bond acceptor attached to C-17 is most likely key to the enhanced activity. Compound 8 displayed significant in vitro antiangiogenic activity, and its ability to act as a microtubule disruptor was confirmed. Inhibitory activity of the sulfamate derivatives against steroid sulfatase and carbonic anhydrase II (hCAII) was also observed, and the interaction between 15 and hCAII was investigated by protein crystallography. The potential of these multimechanism anticancer agents was confirmed in vivo, with promising activity observed for both 14 and 15 in an athymic nude mouse MDA-MB-231 human breast cancer xenograft model.